Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Drug rashes can be an unwanted side effect of many medications. Learn which medications can cause these skin reactions.

Initial results from the ongoing trial saw one patient achieving a complete response in the trial combining Tovecimig with ...

A new drug combination from Corcept Therapeutics, relacorilant, has shown potential in treating platinum-resistant ovarian ...

Can a robot help prepare cancer medication in a hospital pharmacy? That's what hospital pharmacist Tjerk Geersing ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

To advance this research towards commercialization, Daniel Fologea benefits from an NSF Transform grant for marketed oriented ...

Laryngeal cancer affects the larynx (voice box) and often can be curable. Here are the treatment and surgical options and how ...

Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...

Researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

Despite solid data, the lack of high-value indications and no unique platform makes Nuvalent's valuation seem inflated; I ...